Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Neuromelanin is a complex dark pigment found primarily in the catecholaminergic neurons of the substantia nigra and locus coeruleus. It functions as a natural chelator, sequestering iron and other potentially toxic metals to protect neurons from oxidative stress (Zecca et al., 2003). In neurodegenerative conditions like Parkinson's disease, the loss of neuromelanin-containing neurons is a hallmark feature, and the release of the neuromelanin-iron complex into the extracellular space can trigger chronic neuroinflammation (Zucca et al., 2017). While not a classical therapeutic target, neuromelanin is a vital imaging biomarker used to track the progression of dopaminergic neurodegeneration (Sulzer et al., 2018). Research into this area often focuses on iron chelation therapies, such as the use of deferiprone, to reduce the pro-oxidant effects associated with iron accumulation in these specific brain regions. Consequently, these iron-rich brain regions are primary areas of interest for both diagnostic imaging and disease-modifying interventions in Parkinson's disease.
Neuromelanin functions as a high-affinity chelator for transition metals, particularly iron (Fe3+), and sequesters toxic compounds like MPTP, thereby providing neuroprotection under physiological conditions (Zecca et al., 2003). However, in disease states, the breakdown of the neuromelanin-iron complex can lead to the release of redox-active iron, promoting Fenton chemistry and oxidative damage (Zucca et al., 2017).
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Neuromelanin (NM).